FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Sugammadex | Sugammadex sodium 100 mg/mL | Injection, SolutionIntravenous | Lupin Pharmaceuticals, Inc. | Jul 28, 2026 | 70748-371 |
| sugammadex | Sugammadex sodium 100 mg/mL | Injection, SolutionIntravenous | Medical Purchasing Solutions, LLC | Jul 28, 2026 | 71872-7382 |
| Sugammadex | Sugammadex sodium 200 mg/2mL | Injection, SolutionIntravenous | Novadoz Pharmaceuticals LLC | Jul 28, 2026 | 72205-478 |
| Sugammadex | Sugammadex sodium 500 mg/5mL | Injection, SolutionIntravenous | Novadoz Pharmaceuticals LLC | Jul 28, 2026 | 72205-479 |
| sugammadex | Sugammadex sodium 100 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | Jul 28, 2026 | 76045-219 |
| Brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | Jul 28, 2026 | 76282-822 |
| Brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | Jul 28, 2026 | 76282-823 |
| Brivaracetam | Brivaracetam 50 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | Jul 28, 2026 | 76282-824 |
| Brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | Jul 28, 2026 | 76282-825 |
| Brivaracetam | Brivaracetam 100 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | Jul 28, 2026 | 76282-826 |
| Sugammadex Sodium | Sugammadex sodium 200 mg/2mL | SolutionIntravenous | STERISCIENCE SPECIALTIES PRIVATE LIMITED | Jul 28, 2026 | 82449-241 |
| Sugammadex Sodium | Sugammadex sodium 500 mg/5mL | SolutionIntravenous | STERISCIENCE SPECIALTIES PRIVATE LIMITED | Jul 28, 2026 | 82449-242 |
| Sugammadex | Sugammadex sodium 100 mg/mL | InjectionIntravenous | Camber Pharmaceuticals, Inc. | Jul 27, 2026 | 31722-254 |
| Sugammadex | Sugammadex sodium 100 mg/mL | Injection, SolutionIntravenous | Camber Pharmaceuticals, Inc. | Jul 27, 2026 | 31722-255 |
| Valsartan And Hydrochlorothiazide | Valsartan 80 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | ScieGen Pharmaceuticals, INC. | Jul 27, 2026 | 50228-147 |
| Valsartan And Hydrochlorothiazide | Valsartan 160 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | ScieGen Pharmaceuticals, INC. | Jul 27, 2026 | 50228-148 |
| Valsartan And Hydrochlorothiazide | Valsartan 160 mg/1; Hydrochlorothiazide 25 mg/1 | Tablet, Film coatedOral | ScieGen Pharmaceuticals, INC. | Jul 27, 2026 | 50228-149 |
| Valsartan And Hydrochlorothiazide | Valsartan 320 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | ScieGen Pharmaceuticals, INC. | Jul 27, 2026 | 50228-150 |
| Valsartan And Hydrochlorothiazide | Valsartan 320 mg/1; Hydrochlorothiazide 25 mg/1 | Tablet, Film coatedOral | ScieGen Pharmaceuticals, INC. | Jul 27, 2026 | 50228-151 |
| Benazepril Hydrochloride | Benazepril hydrochloride 5 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | Jul 27, 2026 | 62559-524 |
| Benazepril Hydrochloride | Benazepril hydrochloride 10 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | Jul 27, 2026 | 62559-525 |
| Benazepril Hydrochloride | Benazepril hydrochloride 20 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | Jul 27, 2026 | 62559-526 |
| Benazepril Hydrochloride | Benazepril hydrochloride 40 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | Jul 27, 2026 | 62559-527 |
| Hyoscyamine Sulfate | Hyoscyamine sulfate .125 mg/1 | TabletOral | Granulation Technology, Inc. | Jul 27, 2026 | 63561-0203 |
| tramadol hydrochloride | Tramadol hydrochloride 50 mg/1 | TabletOral | Strides Pharma Science Limited | Jul 27, 2026 | 64380-791 |